drugset / Trial / NCT01511302
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether RNS60, in combination with budesonide, is safe in mild to moderate asthmatics when taken by nebulization over a 28-day period, compared to a 28-day control period.
Timeline
- Start
- 2012-06
- Primary completion
- 2013-04
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 0.25 mg | Other |
| Subject | Budesonide | Small molecule | 0.5 mg | Other |
| Subject | RNS60 | Other / unclassified | 2 ml | Other |